Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC1082 Bmv109

Novel fluorescent activity-based probe (ABP), being intrinsically dark and only emitting fluorescence after reaction with the target protease, are ideally suited for imaging techniques such as small animal noninvasive fluorescence imaging and live cell fl

DCC1083 Bmy-25368

Potent long-acting H2-receptor antagonist

86134-80-7
DCC1084 Bnm-iv-147

Novel CD4 mimic, inhibiting HIV-1 entry into target cells with both significantly higher potency and neutralization breadth than previous congeners, while maintaining high selectivity for the target virus

DCC1085 Bnr10s

Solvatochromic Nile Red Probe with FRET Quencher Reveal Lipid Order Heterogeneity in Living and Apoptotic Cells

DCC1086 Bntx Maleatel

Selective delta 1 opioid receptor antagonist

129468-28-6
DCC1087 Bo-1978

Inhibitor of topoisomerase I/II, inducing DNA cross-linking and significantly suppressing the growth of various NSCLC cell lines with or without mutations in epidermal growth factor receptor (EGFR)

DCC1088 Boc-phe-vinyl Ketone

Novel covalent substrate-competitive inactivator of AKT kinase

137278-22-9
DCC1089 bodilisant

Novel Fluorescent, Highly Affine Histamine H3 Receptor Ligand

1416130-06-7
DCC1090 Bodipy495

Fluorogenic dye for Live-Cell Fluorescence Microscopy

121207-31-6
DCC1091 Bodipy625

Novel fluorogenic dye for Live-Cell Fluorescence Microscopy

2183512-02-7
DCC1092 Bonannione A

Natural inhibitor of protein tyrosine phosphatase 1B (PTP1B)

97126-57-3
DCC1093 Bont/a Lc Inhibitor 33

Potent Botulinum Neurotoxin A Light-Chain Inhibitor

DCC1094 Bont-in-33

Novel potent inhibitor of Botulinum neurotoxin/A light chain (BoNT/A LC)

354784-03-5
DCC1095 Bop-jf549

Novel BOP-conjufated fluorescent dual α9β1/α4β1 integrin inhibitor

DCC1096 Bos-318

Novel. highly potent, selective, cell-permeable furin inhibitor, rescuing key features of cystic fibrosis airway disease

DCC1097 Bos-6-2-2-6-crbn

Proteolysis targeting chimeras (PROTAC), acting as a degrader of oncogenic BCR-ABL

DCC1098 Bot-64

Novel IKK-2 inhibitor, targeting the Ser177 and/or Ser181 residues in the kinase's activation loop domain.

113760-29-5
DCC1099 Bp1.4160

Novel and highly potent histamine H3 receptor ligand

914302-67-3
DCC1100 Bp-1-108

Potent and selective STAT5 inhibitor

1334492-85-1
DCC1101 Bp13944

Novel, Potential Dengue Virus NS2B/NS3 Protease Inhibitor

1622060-51-8
DCC1102 Bp2-94

Histamine H3 receptor agonist prodrug

139191-80-3
DCC1103 Bpc Hydroiodide

Novel modulator of TTD-PHD histone reader module, binding to the TTD groove, competing with linker binding and promoting open TTD-PHD conformations

849776-40-5
Page 1271 / Total 1557 FirstPrevNextLastGoto